About us

CEO Message

Dear everyone,
My name is Chihaya Kakinuma, the founder of HOIST Co., Ltd. The name “HOIST” carries the meaning of “Setting new Sails”. After dedicating myself as a researcher in several companies, I have finally gathered the courage to sail into the open sea, instead of seeking “safe harbor”

HOIST Co.,Ltd. President and CEO
An expert in pathology and has long experience in in vitro / in vivo drug efficacy evaluation and toxicity evaluation (including regulatory compliance), and is currently conducting translational research for clinical trials at a bioventure.
  • November 2020 - Present Chief Executive Officer of HOIST Co., Ltd.
  • May 2005 - Octover 2020 Chief researcher, Medical Division, Fujifilm Corporation
  • April 1985 - May 2005 Pharmaceutical Research Institute, Mochida Pharmaceutical Co., Ltd.
  • April 2020 Professor, Center for Innovative Medicine and Science, Wakayama Medical Univ.
  • April 2014 Lecturer, Department of Human Pathology, Juntendo Univ. School of Medicine
  • April 2010 Professor (Visiting), Biopharmaceutical Laboratory, Faculty of Pharmaceutical Sciences, Takasaki Univ. of Health and Welfare
  • January 1999 PhD, Department of Human Pathology, Juntendo University School of Medicine
  • August 1990 Japanese Society of Toxicological Pathology certified toxicological pathology expert
  • August 1990 Japan Veterinary Pathology Professional Association certified pathology specialist
  • March 1985 Japanese veterinarian (national license)

Connecting the results of innovative basic life science research in academia to the clinic through the art of drug discovery. We are committed to creating drugs with breakthrough modalities and mechanisms of action for the treatment of cancers for which there are still no adequate therapies. We have placed the realization of this dream on HOIST Corporation, a bio-venture company originating from Osaka University.

Osaka University, Professor

Company profile

Company name HOIST Co.,Ltd.
Establised on May 30, 2019
Capital 579,289,000 yen
Head Office C807 8th floor Bldg. C, Techno-Alliance Complex, 2-8 Yamadaoka, Suita, Osaka 565-0871 Japan
Laboratory in joint research with Wakayama Medical University 401 CIMS 811-1 Kimiidera, Wakayama-shi 641-8509, Japan
Business Development for cancer drug
Drug discovery support with PDC/PDX
Chief Executive Officer, Rep Director Chihaya KAKINUMA, D.V.M.,PhD.
Chief Operating Officer, Rep Direcor Noriaki KIYA, RPh.,MBA
  • Professor KAZUTAKE TSUJIKAWA (Osaka University)
  • Professor TAKEFUMI DOI (Osaka University)
  • Professor TAKUO OGIHARA (Takasaki University of Health and Welfare)
  • Head Office

  • Laboratory in joint research with Wakayama Medical University